Levomepromazine

Levomepromazine 25 mg
Levomepromazine 25 mgLevomepromazine 25 mgLevomepromazine 25 mgLevomepromazine 25 mgLevomepromazine 25 mg
Nervous System
Albania
No
No
Yes
SA00221
Levomepromazine
25 mg
Sugar coated tablets
Levomepromazine maleate
Box x 30
Sugar coated tablets - 25 mg … Read more

Sugar coated tablets - 25 mg

Levomepromazine belongs to the group of phenothiazine neuroleptics.

It acts on hypothalamus, thalamus, reticular formation and on lymbic system, inhibiting the sensory impulses.

Levomepromazine also has analgesic, antihistaminic and anticholinergic effect.

This medicine does not cause respiratory depression, therefore it is useful especially in patients with low respiratory reserve.

Levomepromazine is used in the treatment of:

- psychoses, to control agitation and psychomotor agitation in moderately severe depression;

- schizophrenia;

- psychotic disorders with hallucinations;

- personality disorders in patients with epilepsy;

- neurotic disorders;

- as an analgesic to relieve moderate to severe pain prior to surgery;

 


Share this  

Recently viewed

Oral drops solution – (10.000 UI + 10.000 UI) / ml

Sugar-coated tablets – 10 mg

Film-coated tablets – 400 mg

Film-coated tablets – 600 mg

Solution for injection - (0.1%) 1 mg/1 ml